| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APOBEC1 complementation factor | 0.604 | 0.692 | 5.9E-10 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2017 | ||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.947 | 90 | 2 | 1986 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 4 | 0.529 | 0.615 | 2.2E-07 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1990 | 1999 | ||||||||
|
ATP binding cassette subfamily B member 5 | 0.623 | 0.538 | 1.5E-37 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 1 | 0.445 | 0.808 | 1.2E-03 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 1994 | 2016 | ||||||||
|
ATP binding cassette subfamily C member 11 | 0.565 | 0.769 | 4.0E-46 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2003 | ||||||||
|
ATP binding cassette subfamily C member 3 | 0.517 | 0.769 | 1.2E-26 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2005 | ||||||||
|
ATP binding cassette subfamily C member 4 | 0.536 | 0.769 | 1.1E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2020 | ||||||||
|
ATP binding cassette subfamily C member 6 | 0.540 | 0.654 | 5.6E-35 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1996 | 2020 | ||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2003 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2000 | 2019 | ||||||||
|
abhydrolase domain containing 2 | 0.729 | 0.346 | 0.68 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
abl interactor 1 | 0.641 | 0.538 | 0.64 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2014 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.985 | 266 | 5 | 1983 | 2019 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2018 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1980 | 2019 | |||||||||
|
ABR activator of RhoGEF and GTPase | 0.650 | 0.500 | 0.63 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
acetyl-CoA carboxylase alpha | 0.480 | 0.846 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2017 | ||||||||
|
ACD shelterin complex subunit and telomerase recruitment factor | 0.603 | 0.731 | 1.1E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.030 | None | 0.667 | 2 | 0 | 2002 | 2019 | ||||||||
|
angiotensin I converting enzyme 2 | 0.477 | 0.769 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1989 | 2018 | ||||||||
|
atypical chemokine receptor 3 | 0.428 | 0.885 | 0.39 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2014 |